GIT2 antibody

Ref. 3D-70R-31878

Produktinformation

• Name: GIT2 antibody

Beschreibung

The GIT2 antibody is a highly specific monoclonal antibody that targets the c-Myc protein, which is an important regulator of cell growth and proliferation. This antibody has been shown to inhibit the activity of c-Myc and block its interaction with other proteins involved in epidermal growth factor signaling. By doing so, it effectively suppresses the growth and survival of cancer cells that overexpress the HER2 receptor. The GIT2 antibody has also demonstrated cytotoxic effects on activated nuclear cells, making it a promising therapeutic option for various types of cancers. Additionally, this antibody has been extensively studied in Life Sciences research and has shown potential in the development of diagnostics and therapeutics for diseases associated with abnormal protein aggregation, such as alpha-synucleinopathies. With its high specificity and potency, the GIT2 antibody holds great promise for advancing our understanding and treatment of various diseases.

• Marke: Biosynth